Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

Clinical trial NCT06608472 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06608472
Sponsor: Eurofarma Laboratorios S.A.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Arterial Hypertension

Start date: 2026-11-30
Primary completion: 2028-04-30
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.